BGMA Sets Out Suggestions For VPAS Overhaul
Generics Body Urges Recognition Of Specificities Of The Off-Patent Medicines Market
Claiming that the UK’s VPAS rebate scheme is “out of control,” local generics and biosimilars association the BGMA has set out a series of suggestions to improve the mechanism, as it continues to battle for formal involvement in negotiations with the government.
